Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine

Bibliographic Details
Main Authors:	Alex Drohan, MD, Glenn Kolansky, MD, Zachary Kolansky, MS
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	JAAD Case Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621005567

Similar Items

A BCC masquerading as a fungating breast mass
by: Zachary Kolansky, et al.
Published: (2022-10-01)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
by: Antonio Cuadrado, et al.
Published: (2022-07-01)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
by: Shara Chopra, BS, BA, et al.
Published: (2021-10-01)

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report
by: Fahad Ahmed, et al.
Published: (2022-12-01)

Pityriasis rubra pilaris potentially triggered by messenger RNA–1273 COVID vaccine
by: Etsubdenk M. Ajebo, MD, et al.
Published: (2022-05-01)

New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
by: Joshua Kaminetsky, et al.
Published: (2021-09-01)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Abdulbaril Olagunju MD, et al.
Published: (2022-04-01)

Livedo reticularis on bilateral knees after the third dose of messenger RNA-1273 SARS-CoV-2 vaccine
by: Michelle Amy Mintz, PhD, et al.
Published: (2022-06-01)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
by: Leelakrishna Channa, BS, et al.
Published: (2021-09-01)

Dyshidrotic bullous pemphigoid developing after Moderna mRNA-1273 vaccination
by: Tyng-Shiuan Hsieh, et al.
Published: (2023-01-01)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
by: Sin Yu Chow, et al.
Published: (2022-11-01)

Transient dermatomyositis-like reaction following COVID-19 messenger RNA vaccination
by: Rodrigo A. Gutierrez, BS, et al.
Published: (2023-07-01)

Cutaneous Sarcoidosis-like Eruption Following Second Dose of Moderna mRNA-1273 Vaccine: Case or Relationship?
by: Gerardo Cazzato, et al.
Published: (2023-03-01)

A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
by: Natia Murvelashvili MD, et al.
Published: (2021-09-01)

Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
by: Masahiro Iwata, et al.
Published: (2023-04-01)

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial
by: Nima S. Hejazi, et al.
Published: (2023-12-01)

Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA−1273
by: Po-Hsu Su, et al.
Published: (2021-11-01)

Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
by: Elif Karatas, MD, et al.
Published: (2023-02-01)

Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review
by: Angel Shabu, et al.
Published: (2023-12-01)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
by: Suresh Babu Chellapandian, et al.
Published: (2022-04-01)

“COVID Arm” in the family medicine setting: Moderna vaccine hypersensitivity reaction
by: Lara L Cohen, et al.
Published: (2022-01-01)

Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
by: Zauraiz Anjum, et al.
Published: (2022-04-01)

Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine
by: Angel Shabu, et al.
Published: (2023-12-01)

New-onset chilblains in close temporal association to mRNA-1273 vaccination
by: Connie Kha, MD, et al.
Published: (2021-06-01)

Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccine
by: Christine Y. Wong, MD, et al.
Published: (2021-10-01)

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
by: Nazmul Islam, et al.
Published: (2022-05-01)

Desmoplastic trichilemoma of the scalp
by: Manuel Valdebran, et al.
Published: (2016-04-01)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
by: Sammy Patyna, et al.
Published: (2022-04-01)

Antibodies against SARS-CoV-2 Alpha, Beta, and Gamma Variants in Pregnant Women and Their Neonates under Antenatal Vaccination with Moderna (mRNA-1273) Vaccine
by: Wei-Chun Chen, et al.
Published: (2022-08-01)

Disseminated varicella-zoster virus infections following messenger RNA–based COVID-19 vaccination
by: Jordan Taylor Said, BA, et al.
Published: (2021-11-01)

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
by: Maria De Santis, et al.
Published: (2022-05-01)

Longitudinal extensive transverse myelitis after COVID-19 vaccination (Spikevax mRNA-1273, Moderna) in a patient with rheumatoid arthritis
by: Saemi Choi, et al.
Published: (2022-12-01)

Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature Review
by: Ruei-Lin Wang, et al.
Published: (2022-08-01)

Suboptimal humoral immunological response to the 2nd dose of anti-COVID19 mRNA-1273 vaccine (Moderna) in kidney transplant patients
by: Jesús Martín-García, et al.
Published: (2023-05-01)

Rare Hypersensitivity Myocardial Reactions Following COVID-19 Vaccination: Hypersensitivity Myocardial Infarction (Kounis Syndrome) and Hypersensitivity Myocarditis
by: Nicholas G. Kounis, et al.
Published: (2022-03-01)

Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient
by: François R. Girardin, et al.
Published: (2022-05-01)

Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech
by: Dulat Bekbolsynov, et al.
Published: (2024-01-01)

Delayed large local reactions to Moderna COVID-19 vaccine: A follow-up report after booster vaccination
by: Kimberly G. Blumenthal, MD, MSc, et al.
Published: (2022-09-01)

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters
by: Bethany Girard, et al.
Published: (2024-03-01)

Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine
by: Yoji Hoshina, et al.
Published: (2022-07-01)